UA106357C2 - Treatment of diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug - Google Patents

Treatment of diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug

Info

Publication number
UA106357C2
UA106357C2 UAA201106012A UAA201106012A UA106357C2 UA 106357 C2 UA106357 C2 UA 106357C2 UA A201106012 A UAA201106012 A UA A201106012A UA A201106012 A UAA201106012 A UA A201106012A UA 106357 C2 UA106357 C2 UA 106357C2
Authority
UA
Ukraine
Prior art keywords
oral
patients
diabetes
glycemic control
treatment
Prior art date
Application number
UAA201106012A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Ева Ульрике Грефе-Моди
Томас Кляйн
Михаэль Марк
Ханс-Йюрген Верле
Original Assignee
Берингер Ингельхайм Интернациональ Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Берингер Ингельхайм Интернациональ Гмбх filed Critical Берингер Ингельхайм Интернациональ Гмбх
Priority claimed from PCT/EP2009/063511 external-priority patent/WO2010043688A1/en
Publication of UA106357C2 publication Critical patent/UA106357C2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to the finding that certain DPP-4 inhibitors are particularly suitable for treating and/or preventing metabolic diseases, particularly diabetes, in patients with insufficient glycemic control despite a therapy with an oral and/or a non-oral antidiabetic drug.
UAA201106012A 2008-10-16 2009-10-15 Treatment of diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug UA106357C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08166829 2008-10-16
PCT/EP2009/063511 WO2010043688A1 (en) 2008-10-16 2009-10-15 Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug

Publications (1)

Publication Number Publication Date
UA106357C2 true UA106357C2 (en) 2014-08-26

Family

ID=52681813

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201106012A UA106357C2 (en) 2008-10-16 2009-10-15 Treatment of diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug

Country Status (2)

Country Link
MY (1) MY174803A (en)
UA (1) UA106357C2 (en)

Also Published As

Publication number Publication date
MY174803A (en) 2020-05-15

Similar Documents

Publication Publication Date Title
MX2020009811A (en) Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug.
MY170728A (en) Treatment for diabetes in patients inappropriate for metformin therapy
MX2011007397A (en) Dpp-iv inhibitors for treatment of diabetes in paediatric patients.
NZ603319A (en) Diabetes therapy
MX2008013304A (en) Glp-1 compounds.
MX2010004450A (en) Bicyclic heterocycle derivatives and methods of use thereof.
WO2010040112A3 (en) Treatment of apolipoprotein-a1 related diseases by inhibition of natural antisense transcript to apolipoprotein-a1
EA201200793A1 (en) TREATMENT OF GENOTYPED PATIENTS WITH DIABETES DPP-4 INHIBITORS, SUCH AS LINAGLIPTIN
PL385586A1 (en) New slow-release insulin analogues
EA201101037A1 (en) TREATMENT OF DIABETES IN PATIENTS WITH Inadequate GLYCEMIC CONTROL, DEPENDING ON THE TREATMENT BY METHORMIN
EP2046973A4 (en) For the identification, assessment, and treatment of patients with cancer therapy
WO2010029089A3 (en) Combination therapy for the treatment of diabetes and related conditions
MX2009011359A (en) Pyrimidinone derivatives and methods of use thereof.
NZ717373A (en) The use of inhibitors of bruton’s tyrosine kinase (btk)
EA201100335A8 (en) PURIN DERIVATIVES FOR USE IN THE TREATMENT OF FAB-ASSOCIATED DISEASES
MX352412B (en) Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript to epo.
MX2012006734A (en) Ppar-sparing thiazolidinediones and combinations for the treatment of obesity and other metabolic diseases.
UA106357C2 (en) Treatment of diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug
BRPI0702847A (en) temozolomide unit dosage forms
TN2011000060A1 (en) Treatment for diabetes in patients inappropriate for metformin therapy
UA85523C2 (en) USE OF N-STEAROYLETHANOLAMINE AS DRUG FOR THERAPY OF diabetes mellitus OF І AND ІІ TYPES
UA37627U (en) Method for treatment of patients with the metabolic syndrome and chronic impaired cardial function
TH112187B (en) Treatment of diabetes mellitus in patients with insufficient glycemic control, despite oral antidiabetic therapy or not oral administration.
UA35671U (en) Method for treating chronic obstructive disease of lungs in setting of hypertension
UA35600U (en) Method for treating chronic obstructive disease of lungs